Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Knowledge of aging biology needs to be expanded due to the continuously growing number
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …
The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic
Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …
infection and severe COVID-19, although they are not the only contributing factor to …
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
Background Some patients with systemic autoimmune rheumatic disease and
immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS …
immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS …
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
D Mrak, D Sieghart, E Simader, S Tobudic… - Nature …, 2022 - nature.com
Impaired response to COVID-19 vaccination is of particular concern in immunosuppressed
patients. To determine the best vaccination strategy for this vulnerable group we performed …
patients. To determine the best vaccination strategy for this vulnerable group we performed …
Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK)
DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - mdpi.com
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …
[HTML][HTML] Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective …
Objectives To characterize the kinetics of humoral and T-cell responses in rheumatoid
arthritis (RA)-patients followed up to 4-6 weeks (T3) after the SARS-CoV-2 vaccine booster …
arthritis (RA)-patients followed up to 4-6 weeks (T3) after the SARS-CoV-2 vaccine booster …
[HTML][HTML] Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with …
Objectives: In this study, we aimed to characterize the SARS-CoV-2-specific T cell response
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …
The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade
UM Geisen, R Rose, F Neumann… - Journal of medical …, 2022 - Wiley Online Library
The humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) vaccination in patients with chronic inflammatory disease (CID) declines more …
CoV‐2) vaccination in patients with chronic inflammatory disease (CID) declines more …
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
D Nemeth, H Vago, L Tothfalusi, Z Ulakcsai… - Frontiers in …, 2022 - frontiersin.org
Background To investigate the factors that have significant impact on the Severe Acute
Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection and vaccination induced …
Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection and vaccination induced …
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different …
Background The decline of humoral response to COVID-19 vaccine led to authorise a
booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in …
booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in …